90% efficacy for Pfizer's COVID-19 mRNA vaccine is striking, but we need to wait for the full data
German biotech company BioNTech and US pharmaceutical Pfizer announced on Monday promising early results from their phase 3 clinical trial for a vaccine against SARS-CoV-2, the virus that causes COVID-19.
Nov 10, 2020
0
3